HOME >> BIOLOGY >> NEWS
BioMed Central to consider charging authors for paper submissions

granting agencies to maximize the impact of the research they have conducted and funded.'

In addition, academic funding bodies have said they are not adverse for grant funding to be allocated to author publication charges. As Bahram Beckradnia, Head of Policy of the UK Higher Education Funding Council for Education (HEFCE) said:

'HEFCE provides a block grant to institutions, and it is for them to decide how it is spent. The payment of publication fees would be a legitimate use of the grant'.

BioMed Central does not envisage levying author charges until 2002 and until this time is holding a debate on this issue where it will listen to feedback from the community.

To either read or contribute to this debate go to: http://www.biomedcentral.com/editorial/charges.asp.


'"/>

Contact: Gordon Fletcher
gordon@biomedcentral.com
44-0-7323-0323
BioMed Central
13-Jul-2001


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. LA BioMed Medical/Research Briefs, July/August 2004
3. BioMed Central explodes Open Access myths
4. The Scientist and BioMed Central come together to publish high-impact magazine
5. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
6. BioMed Central to deposit e-journals with the British Library
7. Get Research on the move with BioMed Central
8. BioMed Central to launch at microbiology meeting
9. BioMed Central to free scientists and clinical researchers from copyright restrictions
10. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
11. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... Mitotech S.A, ... with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and Dermatology, announced ... SkQ1 ophthalmic solution in patients with moderate to severe Dry Eye Disease ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., ... the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New ... treatment of severe COVID-19. Approval of this IND allows Sentien to initiate a ...
(Date:8/12/2020)... ... 11, 2020 , ... Both Roche, based in Basel, Switzerland, ... agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling technology ... and Development spending in excess of US $10 billion. , Scientists at Housey ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... , ... August 03, 2020 , ... ... today announced Jim Corrigan, President and CEO has been named one of the ... cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how they ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... reliable, solid-state radar transmitter systems that can be configured to drive Klystrons, TWTs, ... controller that can drive one or two switches in a push-pull configuration; yielding ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... the top radiation centers in 16 countries, has reached its 20th anniversary of ... now in routine use at top universities including University of Pennsylvania, University of ...
(Date:7/18/2020)... ... 2020 , ... “We are thrilled to deliver this new technology to the ... its kind on the market and we were pleased that the IFT jury recognized ... cultured ingredients, creating a natural way to extend the shelf life and improve the ...
Breaking Biology Technology:
Cached News: